The insider selling is routine and tax/liquidity-driven, not a bearish signal. With 90% analyst bullishness and a $2.4B market cap, the fundamental story (pipeline catalyst) remains intact. Monitor for any upcoming clinical data readout or regulatory update that could be a near-term catalyst.
Price Chart
Executive Summary
Three Pharvaris insiders — the Chief Medical Officer, Chief Early Development Officer, and a Director — sold a total of ~$665K in open-market shares over a 5-day window. The sales are small relative to the $2.4B market cap (~0.03%) and are largely tied to option exercises, suggesting routine tax- and liquidity-driven selling rather than a bearish signal. The cluster is not material enough to change the fundamental outlook for the stock.
Key Financial Metrics
Key Facts
- Three insiders sold a total of ~$665K in open-market shares over June 25-29, 2026.
- Chief Medical Officer Lu Peng sold ~$500K (largest sale), Chief Early Development Lesage Anne sold ~$81K, Director Schikan sold ~$84K.
- All open-market sales were preceded by option exercises at $0 or $2.59 strike, indicating tax-covering and liquidity-driven selling.
- Total open-market sales of ~$665K represent ~0.03% of Pharvaris' $2.4B market cap — well below the 0.1% materiality threshold.
- The cluster is 100% sell-side with no open-market purchases, but the dollar amounts are trivial relative to company size.
Financial Impact
Total open-market sales of ~$665K represent ~0.03% of Pharvaris' $2.4B market cap — immaterial.
Risk Factors
- Insider selling could accelerate if the stock continues to appreciate, but current levels are immaterial.
- Clinical-stage biotech risk: any negative pipeline data would outweigh insider activity entirely.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1782946988269 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $38.06 $36.37 | ▲ +4.44% | ▲ +5.26% | $31.07 (+18.38%) |
Sep 14, 2026 17d ago | 144 | $38.06 $35.20 | ▼ −7.51% | ▼ −9.63% | $31.07 (−18.38%) |
Sep 14, 2026 18d ago | Insider Cluster | $38.86 $36.02 | ▼ −7.31% | ▼ −7.41% | $31.07 (−20.06%) |
Sep 11, 2026 21d ago | Insider Cluster | $38.02 $36.37 | ▼ −4.34% | ▼ −4.12% | $31.07 (−18.29%) |
Sep 8, 2026 24d ago | 6-K | $37.84 $38.86 | ▲ +2.70% | ▲ +3.36% | $31.07 (−17.90%) |
Aug 12, 2026 7w ago | 6-K | $36.46 $36.27 | ▼ −0.52% | ▼ −0.08% | $31.07 (−14.80%) |
Aug 12, 2026 7w ago | Press Release | $36.46 $36.27 | ▼ −0.52% | ▼ −0.08% | $31.07 (−14.80%) |
Aug 6, 2026 8w ago | Press Release | $34.45 $34.04 | ▼ −1.19% | ▼ −2.40% | $31.07 (−9.83%) |
Jul 6, 2026 12w ago | Press Release | $33.22 $35.07 | ▲ +5.57% | ▲ +5.08% | $31.07 (−6.49%) |
Jul 1, 2026 13w ago | Insider Cluster | $33.86 $35.96 | ▲ +6.20% | ▲ +5.27% | $31.07 (−8.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access